| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |